QS
Qizheng Sun
eess.IVcs.CVDrug DiscoveryAerobic exerciseanti-influenza virus agentcond-mat.supr-condistributed learningDrug Designentropy estimationhemagglutinin inhibitors
On Valency
published · living versionsW_phdausf4·v1 · currentpublished
Majorana Edge-to-bound State Transition in Interferometric Superconductor Rings
with Xiangyu Bi, Aoshen Yang, Hongzi Cao, Ganyu Chen +9
1 version
Preprints & journals
16 papers in the corpus · 2011–20262.4 GHz Flip-flop Device within Nonequilibrium Superconducting Diode2606.06152v1 · Xiangyu Bi, Hongyi Li, Aoshen Yang et al.2026 · 0 citationsarXiv
U-Shaped Split Federated Learning with Compact Features for Deep Learning-Based Image Coding.41899983 · Sun, Qizheng, Guo, Caili, Zhu, Meiyi et al.2026 · 0 citationsEntropy (Basel, Switzerland). 2026;28(3)
Deep Joint Source-Channel Coding for Wireless Image Transmission with Semantic Importance2302.02287v1 · Qizheng Sun, Caili Guo, Yang Yang et al.2023 · 24 citationsarXiv
Effects of Aerobic Exercise Combined with Oyster Peptide Supplement on the Formation of CTX-induced Late-Onset Hypogonadism in Male Rats.36097247 · Shi, Wenting, Liu, Yu, Jin, Qiguan et al.2023 · 1 citationReproductive sciences (Thousand Oaks, Calif.). 2023;30(4):1291-1305
Deep Joint Source-Channel Coding Based on Semantics of Pixels2208.11375v1 · Qizheng Sun, Caili Guo, Yang Yang et al.2022 · 1 citationarXiv
Semantic-assisted image compression2201.12599v1 · Qizheng Sun, Caili Guo, Yang Yang et al.2022 · 5 citationsarXiv
Semantic Communications With AI Tasks2109.14170v1 · Yang Yang, Caili Guo, Fangfang Liu et al.2021 · 31 citationsarXiv
Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers.28692292 · Sun, Qi-Zheng, Lin, Gui-Feng, Li, Lin-Li et al.2017 · 46 citationsJournal of medicinal chemistry. 2017;60(14):6337-6352
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.28301150 · Huang, Shenzhen, Song, Chunli, Wang, Xiang et al.2017 · 42 citationsJournal of chemical information and modeling. 2017;57(4):669-679
Progress of small molecular inhibitors in the development of anti-influenza virus agents.28382157 · Wu, Xiaoai, Wu, Xiuli, Sun, Qizheng et al.2017 · 81 citationsTheranostics. 2017;7(4):826-845
Identification of a small molecule that downregulates MITF expression and mediates antimelanoma activity in vitro.26684062 · Cheng, Chuan, Yang, Hui-Wen, Shang, Jin-Feng et al.2017 · 5 citationsMelanoma research. 2016;26(2):117-24
Structural modification of an EGFR inhibitor that showed weak off-target activity against RET leading to the discovery of a potent RET inhibitor.24515340 · Sun, Qi-Zheng, Xu, Yong, Liu, Jing-Jing et al.2015 · 5 citationsMolecular diversity. 2014;18(2):403-9
Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.23362959 · Yang, Ling-Ling, Li, Guo-Bo, Ma, Shuang et al.2013 · 69 citationsJournal of medicinal chemistry. 2013;56(4):1641-55
Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization.22944772 · Yang, Ling-Ling, Li, Guo-Bo, Yan, Heng-Xiu et al.2013 · 44 citationsEuropean journal of medicinal chemistry. 2012;56:30-8
Discovery of the novel potent and selective FLT3 inhibitor 1-5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivo.22452518 · Li, Wei-Wei, Wang, Xiao-Yan, Zheng, Ren-Lin et al.2012 · 34 citationsJournal of medicinal chemistry. 2012;55(8):3852-66
4-(4-Nitro-benz-yl)morpholine.21754051 · Yang, Ling-Ling, Zheng, Ren-Lin, Li, Guo-Bo et al.2011 · 3 citationsActa crystallographica. Section E, Structure reports online. 2011;67(Pt 4):o754
Career total: 29 works. 16 are in this corpus.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.